Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
SSE:600332

Watchlist Manager
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Logo
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
SSE:600332
Watchlist
Price: 29.25 CNY -1.85% Market Closed
Market Cap: 47B CNY
Have any thoughts about
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd?
Write Note

Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
Income from Continuing Operations Peer Comparison

Comparables:
H
3692
600436
600276
000538
S
688506

Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
SSE:600332
Income from Continuing Operations
ÂĄ4B
CAGR 3-Years
1%
CAGR 5-Years
2%
CAGR 10-Years
15%
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Income from Continuing Operations
ÂĄ3.3B
CAGR 3-Years
8%
CAGR 5-Years
11%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Income from Continuing Operations
ÂĄ3B
CAGR 3-Years
16%
CAGR 5-Years
19%
CAGR 10-Years
22%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Income from Continuing Operations
ÂĄ5.4B
CAGR 3-Years
-5%
CAGR 5-Years
4%
CAGR 10-Years
14%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Income from Continuing Operations
ÂĄ4.5B
CAGR 3-Years
-3%
CAGR 5-Years
4%
CAGR 10-Years
6%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Income from Continuing Operations
-ÂĄ780.5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd's Income from Continuing Operations?
Income from Continuing Operations
4B CNY

Based on the financial report for Jun 30, 2024, Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd's Income from Continuing Operations amounts to 4B CNY.

What is Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 10Y
15%

Over the last year, the Income from Continuing Operations growth was -10%. The average annual Income from Continuing Operations growth rates for Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd have been 1% over the past three years , 2% over the past five years , and 15% over the past ten years .

Back to Top